Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
32233-1-PBS targets CRYGD in WB, Indirect ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag37473 Product name: Recombinant human CRYGD protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-120 aa of NM_006891.3 Sequence: MGKITLYEDRGFQGRHYECSSDHPNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNE 相同性解析による交差性が予測される生物種 |
| Full Name | crystallin, gamma D |
| Calculated molecular weight | 21kDa,174aa |
| Observed molecular weight | 18 kDa |
| GenBank accession number | NM_006891.3 |
| Gene Symbol | CRYGD |
| Gene ID (NCBI) | 1421 |
| RRID | AB_3742550 |
| Conjugate | Unconjugated |
| Form | |
| Form | Liquid |
| Purification Method | Antigen affinity Purification |
| UNIPROT ID | P07320 |
| Storage Buffer | PBS only{{ptg:BufferTemp}}7.3 |
| Storage Conditions | Store at -80°C. |
Background Information
CRYGD (Crystallin Gamma D) is a structural protein predominantly expressed in the lens of the eye. It plays a critical role in maintaining lens transparency and refractive index. Mutations in the CRYGD gene are associated with inherited forms of congenital cataracts, making it a genetic target for studying lens development and cataract pathogenesis. It is not a conventional therapeutic drug target but serves as a key marker in ocular disease research.
